---  
layout: startup_page  
title: "HAYA Therapeutics"  
id: "hayatx.com"  
permalink: "/hayatherapeuticshayatx.com02122025/"  
website: "https://www.hayatx.com/"  
funding_round: "Non-dilutive funding"  
funding_amount: "$1.64M"  
investors: "Innosuisse"  
about: "HAYA Therapeutics is a biotechnology company developing precision RNA-guided regulatory genome targeting therapeutics for rare, common, chronic, and age-associated diseases. Their platform focuses on long non-coding RNAs (lncRNAs) to reprogram pathological cell states for diseases like cardiovascular, metabolic, and cancer. HAYA's lead therapeutic candidate is HTX-001, in development for the treatment of heart failure."  
markets: "Biotech, Oncology, Therapeutics"  
hq: "Lausanne, Switzerland"  
founded_year: "2017"  
linkedin: "https://www.linkedin.com/company/haya-therapeutics/"  
twitter: "https://x.com/HAYA_lncRNA"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/haya-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/226594-36"  

date_display: "12-Feb-2025"  
date: "2025-02-12"

# SEO Optimization  
meta_title: "HAYA Therapeutics - Non-dilutive funding Funding ($1.64M)"  
meta_description: "HAYA Therapeutics, HAYA Therapeutics is a biotechnology company developing precision RNA-guided regulatory genome targeting therapeutics for rare, common, chronic, and a..."  
meta_keywords: "HAYA Therapeutics, Biotech, Oncology, Therapeutics, Non-dilutive funding funding"  
canonical_url: "https://startup.projectstartups.com/hayatherapeuticshayatx.com02122025/"  
---